Erenumab Reduces Flushing and Erythema in Rosacea
A calcitonin gene-related peptide inhibitor that is FDA-approved for migraine prevention showed early promise against treatment-resistant redness and flushing of rosacea.
Source: medscape.com
Stay updated with breaking news from Rosacea Quality. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A calcitonin gene-related peptide inhibitor that is FDA-approved for migraine prevention showed early promise against treatment-resistant redness and flushing of rosacea.